License-ready Transdermal Drug Delivery
New Ways to Expand Your Portfolio
Now you have the chance to participate in the transdermal generic space with fentanyl and rivastigmine generic patch licensing opportunities from 3M. You can expand your portfolio and reduce time to market with a partner focused on your success. Available in selected markets. Contact your local 3M Drug Delivery Systems representative to discuss these opportunities.
3M 7-Day Buprenorphine Transdermal Delivery System
The 3M 7-Day Buprenorphine transdermal delivery system is a 7 day patch designed to provide continuous, controlled release of the analgesic buprenorphine through intact skin. This 7-day patch provides excellent dose proportionality - the rate of release of buprenorphine is linearly dependent upon the area of the applied system.
A patch disposal system also available.
3M Fentanyl Transdermal Delivery System
A 3-day patch, the 3M fentanyl transdermal delivery system provides continuous controlled release of fentanyl through intact skin. Available in 6 patch sizes (ranging from 4.72 cm2 to 37.76 cm2), the rate of release is linearly dependent upon the area of the applied patch.
3M Rivastigmine Transdermal Delivery System
A 24-hour patch, the 3M Rivastigmine Transdermal Delivery System provides continuous controlled release of acetylcholinesterase (AChE) inhibitor rivastigmine through intact skin. The 3M patch provides excellent dose proportionality – the rate of release of rivastigmine is linearly dependent upon the area of the applied system.
These licensing opportunities are available in select areas. For details and to discuss your opportunity to license one of these 3M transdermal patch systems, talk to your local 3M representative.
Related Posters, Presentations and Publications
More information coming soon.